Obesity (Silver Spring) by Braun, Joseph M. et al.
Prenatal Perfluoroalkyl Substance Exposure and Child Adiposity 
at 8 Years of Age: The HOME Study
Joseph M. Braun1, Aimin Chen2, Megan E. Romano1, Antonia M. Calafat3, Glenys M. 
Webster4,5, Kimberly Yolton6, and Bruce P. Lanphear4,5
1Department of Epidemiology, Brown University School of Public Health, Brown University, 
Providence, RI
2Department of Environmental Health, University of Cincinnati, Cincinnati, OH 45267
3Centers for Disease Control and Prevention, Atlanta, GA
4Child and Family Research Institute, BC Children’s and Women’s Hospital, Vancouver, Canada
5Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada
6Division of Biostatistics and Epidemiology, Cincinnati Children’s Hospital Medical Center, 
Cincinnati, OH
Abstract
Objective—To examine relationships between prenatal perfluoroalkyl substance (PFAS) 
exposure and adiposity in children born to women who lived downstream from a fluoropolymer 
manufacturing plant.
Methods—Data are from a prospective cohort in Cincinnati, OH (HOME Study). We measured 
perfluorooctanoic (PFOA), perfluorooctane sulfonic (PFOS), perfluorononanoic (PFNA), and 
perfluorohexane sulfonic (PFHxS) acids in prenatal serum samples. We estimated differences in 
body mass index z-scores (BMI), waist circumference, and body fat at 8 years of age (n=204) and 
BMI between 2–8 years of age (n=285) according to PFAS concentrations.
Results—Children born to women in the top two PFOA terciles had greater adiposity at 8 years 
than children in the 1st tercile. For example, waist circumference (cm) was higher among children 
in the 2nd (4.3; 95% CI:1.7, 6.9) and 3rd tercile (2.2; 95% CI:−0.5, 4.9) compared to children in the 
1st tercile. Children in the top two PFOA terciles also had greater BMI gains from 2–8 years 
compared to children in the 1st tercile (p<0.05). PFOS, PFNA and PFHxS were not associated 
with adiposity.
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Conclusions—In this cohort, higher prenatal serum PFOA concentrations were associated with 
greater adiposity at 8 years and a more rapid increase in BMI between 2–8 years.
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Adiposity; children; endocrine disrupting chemicals; obesity; obesogens; perfluoroalkyl 
substances
Introduction
Childhood obesity is a major public health problem in the United States (US), where 17% of 
children are obese and another 15% are overweight.1 Excess adiposity is difficult to reverse 
once established and increases the risk of cardiometabolic, pulmonary, and musculoskeletal 
disorders.2 There is growing evidence that prenatal chemical exposures may play a role in 
childhood obesity risk by perturbing biological pathways involved in energy metabolism, 
appetite, or adipogenesis.3
Perfluoroalkyl substances (PFAS), which have been used in oil and water resistant textile 
coatings, non-stick cookware, food container coatings, floor polish, fire-fighting foam, and 
industrial surfactants, are a class of suspected obesogens that are persistent in the 
environment and humans.4–6 Biomonitoring studies demonstrate nearly ubiquitous exposure 
to four PFAS in the US population: perfluorooctanoic acid (PFOA), perfluorooctane 
sulfonic acid (PFOS), perfluorononanoic acid (PFNA), and perfluorohexane sulfonic acid 
(PFHxS).7,8
Some experimental rodent and in vitro studies show that PFAS exposure may cause 
impaired glucose homeostasis, increased body weight, and altered adipocyte 
differentiation,9–12 while others do not.13 Four prospective epidemiological studies have 
examined the relationship between early life PFAS exposure and child or adult adiposity 
(Table S1).14–17 Two studies reported no associations between prenatal or early childhood 
PFAS exposure and child or adult adiposity.14,15 A third study reported that maternal serum 
PFOA concentrations during pregnancy were associated with increased adiposity, risk of 
being overweight or obese, and serum leptin concentrations in adults.16 A fourth study 
reported more rapid weight gain in girls born to women with higher serum PFOS 
concentrations during pregnancy.17
We used data from a cohort of pregnant women with median serum PFOA concentrations 
that were over two-times higher than pregnant women in the US to examine the relationship 
between prenatal PFAS exposures and longitudinal measures of adiposity in children 
between 2 and 8 years of age.
Methods
Study Participants
We used data from the HOME Study, a prospective cohort study designed to examine the 
impact of early life exposure to prevalent environmental chemicals.18,19 We recruited 
pregnant women from nine prenatal clinics associated with three hospitals in the Cincinnati, 
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Ohio area from March 2003 to January 2006. The eligibility criteria at enrollment were: 1) 
16±3 weeks gestation, 2) ≥18 years old, 3) living in a home built before 1978, 4) no history 
of HIV infection, and 5) not taking any medications for seizure or thyroid disorders. After 
research assistants explained study protocols, all women provided written informed consent 
for themselves and their children. The institutional review boards of Cincinnati Children’s 
Hospital Medical Center, the cooperating delivery hospitals, and the Centers for Disease 
Control and Prevention (CDC) approved this study.
Of the 468 women who initially enrolled in our study, 65 dropped out before delivery. We 
excluded ten women who delivered twins and three who delivered stillborn children. Among 
the remaining 390 singleton children, 222 (57%) completed a follow-up visit at an average 
of 8.1 years of age (range: 7.5–10). Our primary analysis of adiposity at 8 years of age 
included 204 (52%) children after excluding one with a genetic abnormality, three who were 
missing covariates, and 14 whose mothers were missing PFAS concentrations. We 
conducted additional analyses examining BMI, weight, and height z-score trajectories 
between 2 and 8 years of age. Of 316 (81%) children who returned to our study clinic at 
least once between 2 and 8 years of age, we excluded one with a genetic abnormality, four 
who were missing covariates, and 26 whose mothers were missing PFAS concentrations. 
These 285 (73%) children returned for 1,021 study visits at an average of 2.1 (n=243), 3.1 
(n=219), 4.1 (n=167), 5.2 (n=188), or 8.1 (n=204) years of age.
Serum PFAS Concentrations
We collected serial blood samples from women at 16 and 26 weeks gestation and delivery 
and measured serum PFOA, PFOS, PFNA, and PFHxS concentrations using online solid 
phase extraction coupled to high performance liquid chromatography-isotope dilution 
tandem mass spectrometry.20 We analyzed 16-week samples in the majority of women 
(n=173, 87%) to reduce the potential impact of pregnancy-induced changes in serum 
volume. Because some women did not have a sufficient volume of serum from their 16 
week sample to quantify PFAS concentrations, we used their 26-week (n=19, 9%) or birth 
sample (n=8, 4%). The limits of detection for this assay were 0.082 ng/mL (PFNA), 0.1 
ng/mL (PFHxS, PFOA), and 0.2 ng/mL (PFOS). We detected the four PFAS in all samples. 
Each analytic batch included reagent blanks and quality control (QC) materials. The 
coefficients of variation of repeated measurements of the QC materials were ~6%.
Child Anthropometry
Children and their parents returned to our study clinic at 2, 3, 4, 5, and 8 years of age. At 
each study visit, we measured weight to the nearest 0.01 kg with the child dressed in 
undergarments or a dry diaper using a ScaleTronix scale (White Plains, NY). We measured 
height at these same study visits to the nearest 0.1 cm with the child standing straight 
without shoes or head coverings and heels positioned against the wall using an Ayrton 
Stadiometer Model S100 (Prior Lake, MN). At 8 years of age, waist circumference was 
measured by placing a plastic measuring tape around a horizontal plane defined by the left 
and right iliac crests. We also measured children’s body fat using a Tanita children’s body 
fat monitor at 8 years of age (Arlington Heights, IL). We calculated age (in months)- and 
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sex-specific BMI z-scores using US references and considered children overweight or obese 
if their BMI z-score was ≥85th percentile according to NCHS standards.21
Confounding Variables
We selected potential confounders that might be associated with both PFAS concentrations 
and child adiposity using directed acyclic graphs (DAGs). Trained research assistants 
collected covariates using standardized computer-assisted interviews and medical chart 
reviews. Sociodemographic covariates included maternal race, age, education, marital status, 
employment, and household income. Perinatal variables included maternal depressive 
symptoms at 16 weeks gestation (Beck Depression Inventory-II),22 BMI at 16 weeks 
gestation, parity, and serum cotinine (a biomarker of tobacco smoke exposure).23 Dietary 
variables included the frequency of fresh fruit/vegetable and fish consumption during 
pregnancy, as well as prenatal vitamin use.
Statistical Analyses
First, we calculated univariate statistics of PFOA concentrations and BMI z-scores for each 
covariate. We also compared the distribution of PFAS concentrations among HOME Study 
women to the concentration distributions among pregnant women who participated in the 
National Health and Nutrition Examination Survey (NHANES) during the 2003–2004 and 
2005–2006 cycles.
Next, we examined the shape of the relationship between natural log-transformed PFAS 
concentrations and adiposity measurements at 8 years of age using 3-knot restricted cubic 
polynomial splines. We determined if there were non-linear associations by testing the 
significance of the non-linear spline term and examining graphs of the splines.24 We 
observed non-linear associations between PFOA and BMI (non-linearity p-value=0.012), 
waist circumference (non-linearity p-value=0.152), and body fat percent (non-linearity p-
value=0.028). Thus, we examined PFOA using both splines and terciles. The associations 
between PFOS, PFNA, and PFHxS were all linear (non-linearity p-values≥0.199), and we 
categorized them as terciles. We quantified the risk of being overweight or obese at 8 years 
of age according to PFAS terciles using Poisson regression with robust standard errors.
We modeled children’s BMI z-scores between 2 and 8 years of age as a function of PFAS 
tercile, child age in months, an interaction term between age and PFAS tercile, and 
covariates using a linear mixed model with an unstructured covariance matrix to account for 
the correlated and repeated outcome measurements. This model allowed us to estimate the 
average linear BMI z-score slope between 2 and 8 years of age among children in each 
PFAS tercile and determine if these slopes statistically differed from one another.
Finally, because prior studies have observed sex-specific associations between PFAS and 
adiposity, we examined whether child sex modified the association between PFAS 
concentrations and child adiposity at 8 years of age using a product interaction term between 
child sex and PFAS terciles.16
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We also adjusted for prenatal urinary bisphenol A (BPA) concentrations because this 
chemical is a suspected obesogen.18 We measured BPA concentrations in urine samples 
collected from mothers at 16 and 26 weeks gestation using previously described methods.25 
We also adjusted for duration of any breastfeeding and weekly gestational weight gain. 
Finally, we excluded infants who were born small for gestational age (<10th birth weight for 
sex and gestational age percentile) or low birth weight (<2,500 grams).
Results
Geometric mean PFOA (5.4 vs. 5.5 ng/mL), PFOS (13 vs. 13 ng/mL), PFNA (0.9 vs. 1.0 ng/
mL), and PFHxS (1.4 vs. 1.6 ng/mL) concentrations were similar among women whose 
children did and did not complete follow-up at 8 years of age. On average, women included 
in the analysis were 29 years old at delivery (standard deviation [SD]: 5.9) and had an 
annual household income of $55,000 (SD: $42,000). Sixty percent were Caucasian, 45% 
were nulliparous, 62% were married, and 45% had a college degree or greater (Table 1).
Median PFOA concentrations were over 2-times as high among HOME Study women 
compared to pregnant women in the NHANES 2003–2004 and 2005–2006 cycles (5.3 vs. 
2.3 ng/mL) (Figure 1, Table S2). Notably, the 5th percentile of PFOA concentrations (2.4 
ng/mL) among HOME Study women was approximately the median among NHANES 
women. Median PFOS concentrations were slightly higher in the HOME Study women 
compared with NHANES women (13 vs. 11 ng/mL); PFHxS and PFNA concentrations were 
similar in both groups of women.
After adjusting for covariates, the association between PFOA concentrations and all three 
adiposity measurements was positive up to the 50th percentile of PFOA concentrations and 
then declined at concentrations above the 50th percentile (Figure 2 and Table S3). We 
observed a similar dose-response relationship when we examined PFOA terciles and child 
adiposity (Table 2). For example, compared to children in the 1st PFOA tercile, body fat was 
elevated among children born to women in the 2nd tercile (3.6%; 95% CI: 1.8, 5.5), but less 
elevated among children in the 3rd tercile (1.5 %; 95% CI: −0.4, 3.4). Children born to 
women in the 2nd and 3rd terciles of PFOA concentrations had an 84% (RR: 1.84; 95% CI: 
0.97, 3.50) and 54% (RR: 1.54; 95% CI: 0.77, 3.07) increased risk of being overweight or 
obese at 8 years of age compared to children born to women in the 1st tercile, respectively.
Between 2 and 8 years of age, BMI z-scores increased at a greater rate among children in the 
2nd (0.44; 95% CI: 0.23, 0.64; 2nd PFOA tercile×age p-value=0.033) and 3rd (0.37; 95% CI: 
0.14, 0.60; 3rd PFOA tercile×age p-value=0.110) PFOA tercile compared to children in the 
1st tercile (0.12; 95% CI: −0.08, 0.32) (Figure 3). The BMI z-score slope of the top two 
terciles was significantly greater than the slope of the 1st tercile (PFOA×age p-value=0.03). 
These increases in BMI z-score were driven by greater increases in weight relative to height 
between 2 and 8 years of age among children born to women in the top two serum PFOA 
terciles (Supplemental Figure S1).
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PFOS, PFHxS or PFNA concentrations were not associated with child adiposity at 8 years of 
age (Table S4) or changes in BMI z-scores between 2 and 8 years of age (all effect measure 
modification p-value between PFAS tercile and age>0.23).
Child sex did not modify the associations between maternal PFOA, PFOS, or PFNA 
concentrations and adiposity at 8 years of age (effect measure modification p-values>0.20). 
Our results were similar when we excluded children who were born low birth weight or 
small for gestational age, and when we adjusted for prenatal urinary BPA concentrations, 
breastfeeding duration, or gestational weight gain.
Discussion
In this prospective cohort of women with serum PFOA concentrations above the national 
average, we observed that higher PFOA concentrations during pregnancy were associated 
with greater BMI, waist circumference, and body fat in their children at 8 years of age. The 
association between PFOA concentrations and child adiposity was non-linear; adiposity did 
not increase further among children born to women with PFOA concentrations above the 
50th percentile. The increase in body fat we observed among children born to women in the 
2nd and 3rd PFOA terciles was equivalent to a 1.1 and 0.4 kg increase in body fat for a child 
of average weight in the cohort at 8 years of age (29 kg), respectively. In addition, higher 
PFOA concentrations during pregnancy were associated with greater gains in child BMI 
between 2 and 8 years of age. In contrast, maternal serum PFOS, PFNA and PFHxS 
concentrations were not associated with child adiposity at 8 years of age.
Women in our cohort had above average PFOA exposures, with approximately 50% having 
serum PFOA concentrations greater than or equal to the 95th percentile of pregnant women 
in the US at the same time (2003–2006). This allowed us to examine the dose-response 
relationship at these higher levels that were still within the range of interest for the general 
population. The higher serum PFOA concentrations among women in our cohort could be 
due to ingestion of drinking water contaminated with PFOA released by the DuPont 
Washington Works plant in Parkersburg, West Virginia. This plant, located ~250 miles 
upstream of Cincinnati along the Ohio River, has manufactured fluoropolymers since the 
1950s, and as recently as 2000, was emitting over 80,000 lbs of PFOA into the environment 
per year.26,27 Serum PFOA concentrations among pregnant women from the communities 
surrounding this plant are elevated (median: 14.3 ng/mL) due to consumption of PFOA 
contaminated drinking water.26,28 This contamination may affect other communities along 
the Ohio River, including the city of Cincinnati, because they draw their water supplies from 
the river. Indeed, a study of school-age Cincinnati girls observed elevated serum PFOA 
concentrations (median: 7.3 ng/mL) and reported that serum PFOA concentrations were 
positively associated with ingestion of drinking water that may have been contaminated with 
PFOA.29
Four previous cohort studies have examined the associations between PFAS exposures and 
child or adult adiposity (Table S1). A study of 665 adults from Denmark reported that 
prenatal PFOA concentrations were associated with increased BMI and waist circumference 
at 20 years of age, with stronger associations among females.16 Another Danish study of 811 
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children did not observe any associations between prenatal PFOA or PFOS concentrations 
and child BMI or waist circumference at 7 years of age.14 A third study of 447 girls from the 
United Kingdom found that prenatal PFOS concentrations were associated with more rapid 
growth between birth and 20 months of age.17 Finally, a study of 8,764 adults who lived 
near the DuPont Washington Works Plant and had exceptionally high PFOA exposure did 
not find an association between estimated early life PFOA exposure and BMI or risk of 
overweight or obesity.15
Misclassified child or adult adiposity could cause discrepant results across studies. The 
Andersen et al. and Barry et al. studies, which reported no association between PFAS 
exposure and adult or child BMI relied on self- or parent-reported weight and height.14,15 
There are welldocumented errors in self- and parent-reported anthropometry that could 
misclassify BMI and attenuate associations towards the null.30,31 In contrast, the present 
study and the two prior studies reporting associations between prenatal PFAS exposure and 
increased adiposity or accelerated growth used standardized anthropometric measurements 
or clinical records for the majority of participants. These more accurate measures of 
adiposity might have resulted in less misclassification and enhanced statistical precision. 
However, the present study and prior ones are limited by reliance on less-refined measures 
of adiposity. Future studies would benefit from using more detailed adiposity measures, 
including densitometry, bioelectric impedance, or dual energy X-ray absorptiometry.
Repeated assessments of weight and height from 2–8 years of age are a strength of our 
study. These longitudinal data provide additional insight that might not be apparent in 
studies measuring adiposity at only one time point in childhood. An additional strength of 
this study is that we were able to estimate child adiposity using bioelectric impedance at 8 
years of age. However, the relatively modest sample size for analyses of our 8-year 
outcomes limits the statistical precision of these estimates. In addition, while it is possible 
that selection bias could have arisen due to loss to follow-up, this seems unlikely given that 
maternal serum PFAS concentrations were similar between parent/child pairs who did and 
did not complete follow-up at 8 years of age.
We speculate that the non-linear associations we observed between PFOA and adiposity at 8 
years of age may be due to the growth restrictive effect that PFOA has on the fetus and more 
rapid gains in adiposity during childhood.32 This is similar to the phenomenon observed 
among tobacco smoke exposed children who are smaller at birth, grow more rapidly than 
their unexposed peers, and are at increased risk of obesity later in life.33,34 Additional 
follow-up of this cohort will enable us to determine if children with higher prenatal PFOA 
exposure continue to gain adiposity more rapidly and have excess adiposity at later ages.
Our dose-response relationship is consistent with a threshold effect. In vitro studies suggest 
that PFOA exposures above a certain level activate biological mechanisms, like the 
constitutive androstane receptor, that may dampen the obesogenic effects observed at lower 
exposures.35,36 This may be one reason for discrepant findings in prior studies, particularly 
in the study examining exceptionally high PFOA exposure in Ohio and West Virginia. 
Regardless of the biological or non-causal mechanism(s) responsible for our findings, these 
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results highlight the need to consider longitudinal patterns of adiposity and the shape of 
dose-response relationships when studying chemical obesogens.
We found that maternal serum PFOA concentrations, and not the other PFAS, were 
associated with both child adiposity at 8 years of age and accelerated BMI z-score 
trajectories between 2 and 8 years of age. Rodent studies suggest that the effect of prenatal 
PFOA exposure on neonatal death, growth, and development is dependent on the 
peroxisome proliferator activated receptor-α, while prenatal PFOS exposure is not.37 Thus, 
it is possible that individual PFAS act via different mechanisms. Future animal and 
epidemiological studies should continue to investigate this class of chemicals and identify 
potential mechanisms of action that might explain their associations with growth and 
adiposity. In addition to identifying individual chemical obesogens, future studies should 
consider the cumulative or synergistic impact of multiple chemical exposures.
While our unadjusted and covariate-adjusted results were similar (results not shown), 
residual confounding from factors associated with both PFAS exposure and child adiposity 
may have biased our results. This bias may arise if certain maternal dietary patterns or 
behaviors during pregnancy, such as packaged food consumption, were associated with both 
higher PFAS exposure and child dietary patterns that are associated with child adiposity.38 
Water consumption may be another confounder since water contamination is a likely source 
of PFOA exposure in our study participants and it may be associated with lifestyle factors 
that predict subsequent child adiposity. Unfortunately, we did not collect information about 
children’s diet or the water consumption habits of mothers. Finally, children were at 
different stages of pubertal development when they returned for the 8-year visit (range: 7.5–
10 years), which may have influenced their adiposity.39 While we did not measure Tanner 
Stage, future studies should carefully consider whether this adjustment is appropriate since 
PFAS exposure may be associated with later pubertal development.40
Conclusions
In this cohort of pregnant women who had above average serum PFOA concentrations, 
increasing serum PFOA levels during pregnancy were associated with greater BMI, waist 
circumference, and body fat in children at 8 years of age in a non-monotonic fashion. Higher 
serum PFOA concentrations during pregnancy were also associated with more rapid 
increases in BMI in children between 2 and 8 years of age. Other prospective cohort studies 
with longitudinal and detailed measures of child adiposity should confirm these findings.
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• Perfluoroalkyl substances are man-made persistent chemicals and suspected 
obesogens.
• Some studies report that prenatal exposure to perfluoroalkyl substances may 
increase the risk of childhood obesity, but few have examined longitudinal 
patterns of child adiposity.
What this Study Adds
• This study examined longitudinal measures of adiposity from two to eight years 
of age in a prospective cohort of children born to women who lived downstream 
of a fluoropolymer manufacturing plant and had elevated prenatal serum 
perfluorooctanoic acid concentrations.
• Higher prenatal perfluorooctanoic acid concentrations were associated with 
increased adiposity at eight years of age in a non-monotonic fashion, as well as 
more rapid gains in BMI from two to eight years of age.
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Serum PFAS concentrations in pregnant women from the NHANES in the US (n=174) and 
pregnant women from the HOME Study in Cincinnati, OH (n=204) (2003–2006)
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Adjusted restricted cubic polynomial spline of maternal serum PFOA concentrations during 
pregnancy and child BMI z-score, waist circumference, and body fat percent at 8 years of 
age among HOME Study women and their children (n=204)a
a-Adjusted for maternal age, race, education, income, parity, employment, marital status, 
depressive symptoms, BMI at 16 weeks gestation, fruit/vegetable consumption, fish 
consumption, prenatal vitamin use, and maternal serum cotinine concentrations. The waist 
circumference model is also adjusted for child age in months.
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The solid line represents the mean BMI, waist circumference, or body fat percent from the 
adjusted restricted cubic polynomial spline. The shaded area is the 95% confidence interval. 
The non-linearity p-values were 0.002, 0.019, and 0.002 for BMI z-scores, waist 
circumference, and body fat % models, respectively. Estimated mean differences in 
adiposity at 8 years of age according to various maternal PFOA concentrations are presented 
in Table S3.
The point estimates represent the mean BMI, waist circumference, or body fat percent for 
the 1st (0.5–4.2 ng/mL), 2nd (4.3–6.4 ng/mL), and 3rd (6.6–25 ng/mL) maternal PFOA 
terciles. The errors bars represent the 95% CI of these means.
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Adjusted BMI z-scores slopes between 2 and 8 years of age by maternal PFOA 
concentration tercile among HOME Study women and their children (n=285, 1,012 repeated 
observations)a
a-Adjusted for maternal age, race, education, income, parity, employment, marital status, 
depressive symptoms, BMI at 16 weeks gestation, fruit/vegetable consumption, fish 
consumption, prenatal vitamin use, maternal serum cotinine concentrations, and child age in 
months.
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Table 1
Maternal serum PFOA concentrations (ng/mL) and child BMI z-scores at 8 years of age according to maternal 
sociodemographic, perinatal, dietary, and environmental factors during pregnancy (HOME Study)




Overall 204 5.3 (3.7, 7.7) 0.35 (1.0)
Maternal Age
18–25 years 55 (27) 6.1 (4.4, 8.4) 0.41 (1.06)
>25–35 years 120 (59) 4.7 (3.6, 7.0) 0.37 (0.98)
>35 years 29 (14) 5.5 (4.0, 9.4) 0.19 (0.97)
p-value 0.144 0.628
Maternal Race
White 122 (60) 5.6 (3.8, 9.0) 0.18 (0.94)
Black 72 (35) 4.9 (3.7, 6.2) 0.67 (0.96)
Other 10 (5) 6.4 (3.7, 10) 0.25 (1.44)
p-value 0.007 0.003
Maternal Education
Bachelor's/Grad/Professional 92 (45) 5.4 (3.9, 8.9) 0.32 (0.92)
Tech school/Some College 59 (29) 5.4 (3.6, 7.3) 0.01 (1.05)
High School or Less 53 (26) 5.0 (3.8, 7.2) 0.80 (0.93)
p-value 0.612 <0.0001
Marital Status
Married 126 (62) 5.3 (3.7, 8.9) 0.25 (0.97)
Not Married 78 (38) 5.4 (4.0, 7.2) 0.52 (1.02)
p-value 0.330 0.067
Income
>$80,000 52 (25) 5.7 (3.8, 9.9) 0.26 (0.87)
$40–80,000 65 (32) 5.3 (4.2, 7.2) 0.24 (0.95)
$20–40,000 33 (16) 5.5 (4.0, 6.6) 0.36 (1.09)
<$20,000 54 (26) 4.8 (3.6, 6.6) 0.58 (1.10)
p-value 0.096 0.256
Parity
0 92 (45) 6.5 (5.1, 9.6) 0.27 (1.03)
1 59 (29) 4.6 (3.5, 5.7) 0.37 (0.95)
2+ 53 (26) 4.2 (3.4, 7.1) 0.48 (1.00)
p-value <0.0001 0.473
Depressive Symptoms
Minimal: <14 160 (78) 5.4 (3.7, 8.1) 0.28 (0.97)
Mild: 14–19 25 (12) 6.0 (4.1, 8.8) 0.45 (1.01)
Moderate/Severe 19 (9) 4.3 (3.5, 5.3) 0.82 (1.17)
p-value 0.012 0.072
Serum Cotinine
<LOD 66 (32) 4.7 (3.5, 6.2) 0.26 (0.91)
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LOD - 3 ng/mL 115 (56) 6.0 (4.2, 9.0) 0.38 (1.03)
>3 ng/mL 23 (11) 4.3 (3.6, 5.5) 0.52 (1.11)
p-value 0.052 0.517
Employment
Unemployed 40 (20) 5.0 (3.3, 5.9) 0.51 (1.08)
Employed 164 (80) 5.5 (4, 8.3) 0.32 (0.98)
p-value 0.040 0.263
Fresh Fruit and Veg
Monthly 25 (12) 5.8 (3.3, 6.6) 0.37 (0.72)
Weekly 109 (53) 5.5 (4.2, 7.9) 0.36 (0.99)
Daily or More 70 (34) 4.7 (3.5, 8.8) 0.34 (1.10)
p-value 0.066 0.983
BMI
<25 85 (42) 5.4 (3.9, 8.9) −0.01 (0.96)
25–30 67 (33) 5.0 (3.7, 7.7) 0.39 (0.86)
>30 52 (25) 5.2 (3.7, 7.3) 0.90 (0.98)
p-value 0.469 <0.001
Prenatal Vitamins
Rarely/Never 29 (14) 5.0 (3.8, 6.0) 0.46 (1.18)
Weekly/Daily 175 (86) 5.4 (3.7, 8.1) 0.34 (0.97)
p-value 0.170 0.517
Fish Intake
None 29 (14) 5.3 (3.7, 7.4) 0.60 (0.09)
Any 175 (86) 5.4 (3.7, 7.7) 0.31 (1.01)
p-value 0.780 0.145
The p-values are from linear regression models regressing BMI z-scores or natural log-transformed PFOA concentrations on each covariate.
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